NCBI PubMed Central
open access
Targeting mitochondria for the treatment of neurodegenerative diseases.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 21 U.S.C. § 360ee-1 — FDA rare neurodegenerative disease grant program#577348
- Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson’s Disease#486474
- Peroxisome proliferator activator receptor gamma coactivator-1α overexpression in amyotrophic lateral sclerosis: A tale of two transgenics#1005406
- A Trial of MitoQ for the Treatment of People With Parkinson's Disease#1094997
- Potentiation of mitochondrial function by mitoDREADD-Gs reverses pharmacological and neurodegenerative cognitive impairment in mice#370253
Record · ID 430890
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive